NEXENTIS TECHNOLOGIES INC. Payments to Fund Long-term Loans to Related Parties
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Payments to Fund Long-term Loans to Related Parties of $406.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToFundLongtermLoansToRelatedParties · last filed 2026-03-31
- NEXENTIS TECHNOLOGIES INC. payments to fund long-term loans to related parties for the quarter ending 2024-12-31 was $0.00.
- NEXENTIS TECHNOLOGIES INC. payments to fund long-term loans to related parties for fiscal 2024 was $406.00K.
| Period end | Payments to Fund Long-term Loans to Related Parties 3 month | Payments to Fund Long-term Loans to Related Parties 9 month | Payments to Fund Long-term Loans to Related Parties 9 month as first filed | Payments to Fund Long-term Loans to Related Parties 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $406.00K 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $406.00K 10-Q · filed 2025-11-13 | $406.46K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |